The African Union Commission has launched a consortium for vaccine clinical trials aimed at securing more than 10 late-stage trials as early as possible.
The new consortium will be headed by the Africa Centres for Disease Control and Prevention.
It will bring together global vaccine developers, funders, and African organisations that facilitate clinical trials to ensure that sufficient data on effects of vaccine candidates on African population is generated so they can be confidently rolled out in Africa once vaccines are approved.
The AU Commission says rolling out a vaccine in Africa is key to “limiting transmission, preventing deaths and laying the foundation for socio-economic recovery that should bring Africa’s integration agenda back on track”.
“Success in developing and providing access to a safe vaccine requires an innovative and collaborative approach, with significant local manufacturing in Africa. We need to support the contribution of African scientists and healthcare professionals. We need to act with urgency,” said AU Chairperson President Cyril Ramaphosa.
South Africa and Egypt are already running human trials for a potential vaccine.